webinar register page

Webinar banner
A Pharmacist Roundtable: Leveraging the Power of Treatment Intensification as a Team to Improve BP Control
Learning objectives for this one-hour webinar:
• Outline the import role of treatment intensification in lowering blood pressure and risk of heart attack and stroke
• Describe common patient, provider, and healthcare system challenges to treatment intensification
• Identify models of care, tools, and resources to systematically improve treatment intensification and medication adherence

Guest panelists:
• C. Adair Blyler, PharmD, CHC, Cedars-Sinai Medical Center, Los Angeles, CA
• Eric J. MacLaughlin, PharmD, FASHP, FCCP, BCPS, Texas Tech University Health Sciences Center, Amarillo, TX
• Adam Bress, PharmD, MS, University of Utah, Salt Lake City, UT

Pre-requisites - Audience is encouraged to watch the below webinar and read reference articles (copy and paste URL into web browser for access)
1. Watch “Acting Rapidly with Pharmacotherapy - Step 2 in Hypertension Control” webinar (Egan) via this link: https://targetbp.org/tools_downloads/cme-course-acting-rapidly-with-pharmacotherapy-step-2-in-hypertension-control/
2. Bellows BK, Ruiz-Negrón N, Bibbins-Domingo K, King JB, Pletcher MJ, Moran AE, Fontil V. Clinic-based strategies to reach United States million hearts 2022 blood pressure control goals. Circ Cardiovasc Qual Outcomes. 2019;12:e005624. DOI: 10.1161/CIRCOUTCOMES.118.005624
3. Tracking Blood Pressure Control Performance and Process Metrics in 25 US Health Systems: The PCORnet Blood Pressure Control Laboratory. Journal of the American Heart Association https://www.ahajournals.org/doi/full/10.1161/JAHA.121.022224
4. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association. Hypertension. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000203

Jun 7, 2022 11:00 AM in Central Time (US and Canada)

* Required information


C. Adair Blyler, PharmD, CHC
Clinical Pharmacist and Researcher @Smidt Heart Institute at Cedars Sinai Medical Center
Dr. Blyler is a clinical pharmacist and researcher at the Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles, CA. Her research is focused on the prevention and treatment of cardiovascular disease and reducing health disparities through community-based practice. She served as one of two full-time clinical research pharmacists on an NIH/NHLBI funded randomized trial that investigated a novel community-based approach to treat hypertension in African American male patients involving pharmacists, barbers and physicians. The highly successful intervention was recognized by the Clinical Research Forum as the ‘Top Research Achievement of the Year.’ Dr. Blyler has spoken about this work at multiple national meetings including American Heart Association (AHA) Scientific Sessions, AHA Hypertension Sessions, the National Academies of Science, Engineering and Medicine (NASEM), American Society of Nephrology (ASN) Kidney Week, and the National Medical Association annual meeting.
Eric MacLaughlin, PharmD, FASHP, FCCP, BCPS
Professor and Chair, Department of Pharmacy Practice @Texas Tech University Health Sciences Center, Jerry H. Hodge School of Pharmacy
Eric MacLaughlin, Pharm.D., FASHP, FCCP, BCPS is Professor and Chair, Department of Pharmacy Practice at Texas Tech University Health Sciences Center (TTUHSC), Jerry H. Hodge School of Pharmacy. He is also a Clinical Professor in the Departments of Family Medicine and Internal Medicine at the TTUHSC School of Medicine. Dr. MacLaughlin practices in family medicine providing team-based comprehensive medication management services for patients with hypertension, diabetes, and other chronic diseases. He is a Certified Hypertension Clinician and was the pharmacist member of the Guideline Writing Committee for the 2017 ACC/AHA Guideline for the Prevention, Detection, and Management, of High Blood Pressure in Adults. Dr. MacLaughlin’s teaching, practice, and research focus are on chronic cardiovascular diseases, particularly high blood pressure, and team-based care.
Adam Bress, PharmD, MS
Associate Professor, Population Health Sciences with Tenure and Investigator @Division of Health System Innovation and Research, VA Salt Lake City Health Care System
Adam Bress is currently an Associate Professor of Population Health Sciences with Tenure in the Division of Health System Innovation and Research and an Investigator at the VA Salt Lake City Health Care System. Dr. Bress received his Doctor of Pharmacy degree from the University of Maryland, and his Masters of Science in Clinical and Translational Science from the University of Illinois at Chicago School of Public Health with a focus on epidemiology. He completed his residency in pharmacy practice at Yale-New Haven Hospital and Cardiology at the University of Illinois at Chicago. He subsequently completed his post-doctoral research fellowship in cardiovascular pharmacogenomics at the University of Illinois at Chicago. As a formally-trained cardiovascular clinical pharmacist and population scientist, Br. Bress’s research is NIH-funded and focused on the prevention and treatment of cardiovascular disease, optimizing cardiovascular medication use, and reducing health disparities.